SRC and cancer: Sex hormone and androgen-metabolite induction of Src, Raf-1, ERK1/2, MEK, and CREB activation [126, 127] were mediated by androgen and estradiol treatment-induced AR association (within 1-min) to the SH3 kinase domain of Src in cancer cell lines [124].